C4 Therapeutics (CCCC) IPO Opens 40% Higher

Today's IPO for C4 Therapeutics, Inc. (C4T) (NASDAQ: CCCC) opened for trading at $26.60 after pricing of its upsized initial public offering of 9.6 million shares of common stock at a public offering price of $19 per share.

Additionally, C4T has granted the underwriters a 30-day option to purchase up to an additional 1.44 million shares of common stock at the initial public offering price, less underwriting discounts and commissions.

Jefferies, Evercore ISI, BMO Capital Markets and UBS Investment Bank are acting as joint book-running managers for the offering.

You May Also Be Interested In

• Ares Acquisition Corporation III prices $345M IPO on NYSE
• Futurewave Acquisition prices $75M IPO on Nasdaq
• BMO Capital Upgrades Casey's General Stores (CASY) to Outperform, 'Opportunity Knocks'